Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D L Cutler

Showing results (31-40 of 55) with videos related to

Pageof 6
Sort By:
Community Mental Health Journal|January 1, 1987
Academic, community and state mental health program collaboration: the Oregon experienceL R Faulkner, J D Bloom, D L Cutler, et al.
Clinical Pharmacology and Therapeutics|February 11, 2000
In vivo effects of interleukin-10 on human cytochrome P450 activityJ C Gorski, S D Hall, P Becker, et al.
Cancer Chemotherapy and Pharmacology|September 29, 1999
Effect of gastric pH on the relative oral bioavailability and pharmacokinetics of temozolomideP Beale, I Judson, S Moore, et al.
Psychiatric Services (Washington, D.C.)|September 15, 1998
A three-decade perspective on community and public psychiatry training in OregonR Goetz, D L Cutler, D Pollack, et al.
Journal of Clinical Pharmacology|July 14, 2017
The Effect of Renal Impairment on the Pharmacokinetics and Pharmacodynamics of Ertugliflozin in Subjects With Type 2 Diabetes MellitusV Sahasrabudhe, S G Terra, A Hickman, et al.
Metabolism: Clinical and Experimental|October 1, 1995
Low-carbohydrate diet alters intracellular glucose metabolism but not overall glucose disposal in exercise-trained subjectsD L Cutler, C G Gray, S W Park, et al.
Pharmaceutical Research|January 19, 1999
Pharmacokinetics and leukocyte responses of recombinant human interleukin-10E Radwanski, A Chakraborty, S Van Wart, et al.
Mental Health Services Research|March 21, 2001
Psychiatric hospitalizations, arrests, emergency room visits, and homelessness of clients with serious and persistent mental illness: findings from a randomized trial of two ACT programs vs. usual careG N Clarke, H A Herinckx, R F Kinney, et al.
British Journal of Clinical Pharmacology|March 12, 1999
Pharmacokinetics of flutamide in patients with renal insufficiencyS Anjum, S K Swan, L J Lambrecht, et al.
Clinical Pharmacology and Therapeutics|August 1, 1997
Pharmacodynamics of subcutaneous recombinant human interleukin-10 in healthy volunteersR D Huhn, E Radwanski, J Gallo, et al.
Pageof 6

Showing results (31-40 of 55) with videos related to

Sort By:
Pageof 6
Community Mental Health Journal|January 1, 1987
Academic, community and state mental health program collaboration: the Oregon experienceL R Faulkner, J D Bloom, D L Cutler, et al.
Clinical Pharmacology and Therapeutics|February 11, 2000
In vivo effects of interleukin-10 on human cytochrome P450 activityJ C Gorski, S D Hall, P Becker, et al.
Cancer Chemotherapy and Pharmacology|September 29, 1999
Effect of gastric pH on the relative oral bioavailability and pharmacokinetics of temozolomideP Beale, I Judson, S Moore, et al.
Psychiatric Services (Washington, D.C.)|September 15, 1998
A three-decade perspective on community and public psychiatry training in OregonR Goetz, D L Cutler, D Pollack, et al.
Journal of Clinical Pharmacology|July 14, 2017
The Effect of Renal Impairment on the Pharmacokinetics and Pharmacodynamics of Ertugliflozin in Subjects With Type 2 Diabetes MellitusV Sahasrabudhe, S G Terra, A Hickman, et al.
Metabolism: Clinical and Experimental|October 1, 1995
Low-carbohydrate diet alters intracellular glucose metabolism but not overall glucose disposal in exercise-trained subjectsD L Cutler, C G Gray, S W Park, et al.
Pharmaceutical Research|January 19, 1999
Pharmacokinetics and leukocyte responses of recombinant human interleukin-10E Radwanski, A Chakraborty, S Van Wart, et al.
Mental Health Services Research|March 21, 2001
Psychiatric hospitalizations, arrests, emergency room visits, and homelessness of clients with serious and persistent mental illness: findings from a randomized trial of two ACT programs vs. usual careG N Clarke, H A Herinckx, R F Kinney, et al.
British Journal of Clinical Pharmacology|March 12, 1999
Pharmacokinetics of flutamide in patients with renal insufficiencyS Anjum, S K Swan, L J Lambrecht, et al.
Clinical Pharmacology and Therapeutics|August 1, 1997
Pharmacodynamics of subcutaneous recombinant human interleukin-10 in healthy volunteersR D Huhn, E Radwanski, J Gallo, et al.
Pageof 6